HomeOwner SearchCategory Search
Visit USCODiabetes Technology & Therapeutics [Published: 2021-01-28 to 2021-02-25. Issues: vol. 23, no. 2, February 2021 to vol. 23, no. 3, March 2021]
Serial Registration
Copyright Title
Diabetes Technology & Therapeutics [Published: 2021-01-28 to 2021-02-25. Issues: vol. 23, no. 2, February 2021 to vol. 23, no. 3, March 2021]
Status
Published
on 8 Jun 2021
Year of Creation
2021
Copyright Claimant
Mary Ann Liebert, Inc
Registration Number
TX0008999757
on 8 Jun 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008999757) dated 8 Jun 2021, pertains to an electronic file (eService) titled "Diabetes Technology & Therapeutics [Published: 2021-01-28 to 2021-02-25. Issues: vol. 23, no. 2, February 2021 to vol. 23, no. 3, March 2021]" created in 2021. The copyright holder is Mary Ann Liebert, Inc, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Mary Ann Liebert, Inc.
Application Details
Registration Number
TX0008999757
Registration Date
6/8/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Mary Ann Liebert, Inc
Physical Description
Electronic file (eService)
First Publication Nation
United States
ISSN
1557-8593
Notes
Rights Note: Mary Ann Liebert, Inc., 140 Hugenot St, 3rd Floor, New Rochelle, NY, 10801, United States
Copyright Local Holdings: vol. 23, no. 2, February 2021 (C.O. correspondence) Pub. 2021-01-28 Regarding group registration: A group of serial issues may be registered on one application with one filing fee only under limited circumstances. ALL of the following are required: (1) Each issue must be a serial, as defined in 37 C.F.R. 202.4(d); (2) the group must include at least two issues; (3) each issue must be an all-new collective work that has not been previously published; (4) each issue must be fixed and distributed as a discrete, self-contained collective work, and the claim in each issue must be limited to the collective work; (5) each issue must be a work made for hire; (6) the author and claimant for each issue must be the same person or organization; (7) the serial generally must be published at intervals of a week or more; (8) all of the issues must be published under the same continuing title; (9) all of the issues must be published within three months and within the same calendar year; and (10) the applicant must specify the date of publication for each issue in the group Reg. 2021-06-16 TX0008999757 HMARvol. 23, no. 3, March 2021 (C.O. correspondence) Pub. 2021-02-25 Regarding group registration: A group of serial issues may be registered on one application with one filing fee only under limited circumstances. ALL of the following are required: (1) Each issue must be a serial, as defined in 37 C.F.R. 202.4(d); (2) the group must include at least two issues; (3) each issue must be an all-new collective work that has not been previously published; (4) each issue must be fixed and distributed as a discrete, self-contained collective work, and the claim in each issue must be limited to the collective work; (5) each issue must be a work made for hire; (6) the author and claimant for each issue must be the same person or organization; (7) the serial generally must be published at intervals of a week or more; (8) all of the issues must be published under the same continuing title; (9) all of the issues must be published within three months and within the same calendar year; and (10) the applicant must specify the date of publication for each issue in the group Reg. 2021-06-16 TX0008999757 HMAR
Local Copyright Note: C.O. correspondenceRegarding group registration: A group of serial issues may be registered on one application with one filing fee only under limited circumstances. ALL of the following are required: (1) Each issue must be a serial, as defined in 37 C.F.R. 202.4(d); (2) the group must include at least two issues; (3) each issue must be an all-new collective work that has not been previously published; (4) each issue must be fixed and distributed as a discrete, self-contained collective work, and the claim in each issue must be limited to the collective work; (5) each issue must be a work made for hire; (6) the author and claimant for each issue must be the same person or organization; (7) the serial generally must be published at intervals of a week or more; (8) all of the issues must be published under the same continuing title; (9) all of the issues must be published within three months and within the same calendar year; and (10) the applicant must specify the date of publication for each issue in the group
Statements
Application Title Statement: Diabetes Technology & Therapeutics
Author Statement: Mary Ann Liebert, Inc employer for hire Authorship: collective work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.